Dörffel Debora, Klotz Edda, Wagner Patrick, Ehrig Karsten, Pretzel Karin, Hanisch Falko, Pruß Axel
Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany.
J Extra Corpor Technol. 2025 Jun;57(2):89-95. doi: 10.1051/ject/2025013. Epub 2025 Jun 16.
The use of cell salvage reduces homologous blood transfusions during operations and avoids associated complications. Therefore, autotransfusion is an integral part of Patient Blood Management (PBM). The quality control of cell salvage in Germany is performed by checking the target values of a hematocrit in the autotransfusion blood (target: over 50%) and a total protein elimination (target: over 90%). The aim of this study was to identify intraoperative circumstances leading to deviations from the target values.
This retrospective data analysis includes the use of the cell saver at the Charité - Universitätsmedizin Berlin, Campus Charité Mitte and Campus Benjamin Franklin from 01.01.2019 to 29.03.2022, in which autotransfusion occurred. In addition to the hematocrit and total protein elimination, the age and gender of the patients, as well as the surgical diagnosis, were included to investigate possible factors influencing compliance with the target values. The data were statistically analyzed using SPSS.
A total patient collective of 238 cell salvage applications (154 men, 84 women) was examined. The target values for quality control were achieved on average. The target value for hematocrit was not achieved in about 22% and for total protein elimination in about 8% of cell salvage applications. The age and gender of the patient, as well as the surgical diagnosis, had very little to no influence on compliance with the target values. The target values were not met primarily when the emergency option of the cell saver was used, when the collection volume was too low or when the collection volume was heavily diluted with rinsing fluid.
The target values for quality control were achieved in most of the cell salvage applications examined and are suitable for ensuring the quality of autotransfusion. Special clinical circumstances may lead to the treating anesthetist having to accept deviating collection volumes or washing processes.
细胞回收利用可减少手术期间的同源输血,并避免相关并发症。因此,自体输血是患者血液管理(PBM)的一个重要组成部分。德国细胞回收利用的质量控制是通过检查自体输血血液中的血细胞比容目标值(目标:超过50%)和总蛋白清除率(目标:超过90%)来进行的。本研究的目的是确定导致偏离目标值的术中情况。
这项回顾性数据分析包括2019年1月1日至2022年3月29日在柏林夏里特大学医学中心米特区校区和本杰明·富兰克林校区使用细胞回收器且进行了自体输血的情况。除了血细胞比容和总蛋白清除率外,还纳入了患者的年龄和性别以及手术诊断,以调查影响目标值达标情况的可能因素。使用SPSS对数据进行统计分析。
共检查了238例细胞回收利用的病例(154例男性,84例女性)。质量控制的目标值平均得以实现。在约22%的细胞回收利用病例中未达到血细胞比容目标值,在约8%的病例中未达到总蛋白清除率目标值。患者的年龄和性别以及手术诊断对目标值达标情况的影响很小或几乎没有影响。主要在使用细胞回收器的紧急选项、收集量过低或收集量被冲洗液严重稀释时未达到目标值。
在所检查的大多数细胞回收利用病例中实现了质量控制目标值,这些目标值适用于确保自体输血的质量。特殊的临床情况可能导致主治麻醉师不得不接受偏离的收集量或冲洗过程。